Hunan Cancer Hospital — Changsha

Public research footprint of Hunan Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

779

Registered studies

432

Active

249

Recruiting now

172

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Cancer · Relapsed/Refractory Follicular Lymphoma · HR Low-Positive/HER2-Negative Breast Neoplasms

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT06793215 — A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hunan Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.